Tsuchimoto Kim R — SEC Form 4 filings
SEC reporting owner CIK 1333516. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-04-02 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 3 filings — 17,084 shares, $1,267,304 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 8,904 shares @ $40.00 ($356,171) in Monopar Therapeutics, filed 2025-07-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Monopar Therapeutics (MNPR) | Director | 7 | — | 13 legs · 17,084 sh · $1,267,304 | 15 |
Form 4 filings — Tsuchimoto Kim R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4/A | Monopar Therapeutics (MNPR) | Option exercise (M): 2,055 @ $30 · Option exercise (M): 2,035 @ $14 · Sale (S): 485 @ $108.83 · Sale (S): 615 @ $109.56 · Sale (S): 700 @ $110.65 · Sale (S): 1,098 @ $111.84 · +4 more | EDGAR |
| 2026-08-27 | 4 | Monopar Therapeutics (MNPR) | Sale (S): 485 @ $108.83 · Sale (S): 615 @ $109.56 · Sale (S): 700 @ $110.65 · Sale (S): 1,098 @ $111.84 · Sale (S): 602 @ $112.93 · Sale (S): 590 @ $113.84 | EDGAR |
| 2025-12-08 | 4 | Monopar Therapeutics (MNPR) | Grant/award (A): 2,924 (derivative) @ $0 | EDGAR |
| 2025-07-16 | 4 | Monopar Therapeutics (MNPR) | Option exercise/expiry (X): 8,904 @ $0.01 · Sale (S): 8,904 @ $40.00 · Option exercise/expiry (X): 4,200 (derivative) @ $0 · Option exercise/expiry (X): 4,704 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Monopar Therapeutics (MNPR) | Grant/award (A): 11,365 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Monopar Therapeutics (MNPR) | Option exercise (M): 9,957 · Tax withholding (F): 2,998 @ $0.73 · Option exercise (M): 9,957 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Monopar Therapeutics (MNPR) | Option exercise (M): 9,956 · Tax withholding (F): 4,082 @ $0.68 · Option exercise (M): 9,956 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1333516 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →